Matrix Metalloproteinases/Tissue Inhibitors of Metalloproteinases: Relationship Between Changes in Proteolytic Determinants of Matrix Composition and Structural, Functional, and Clinical Manifestations of Hypertensive Heart Disease - Ahmed, S. Hinan; Clark, Leslie L.; Pennington, Weems R.; Webb, Carson S.; Bonnema, D. Dirk; Leonardi, Amy H.; McClure, Catherine D.; Spinale, Francis G.; Zile, Michael R. (Circulation (New York, N.Y.), 2006)
Keywords: Aged; Biological and medical sciences; Blood and lymphatic vessels; Blood coagulation; Cardiology. Vascular system; Collagenases - blood; Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous; Female; Heart Failure - enzymology; Heart Failure - physiopathology; Humans; Hypertension - complications; Hypertrophy, Left Ventricular - enzymology; Hypertrophy, Left Ventricular - physiopathology; Investigative techniques, diagnostic techniques (general aspects); Male; Matrix Metalloproteinase 13; Matrix Metalloproteinase 2 - blood; Matrix Metalloproteinase 9 - blood; Matrix Metalloproteinases - blood; Medical sciences; Middle Aged; Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis; Tissue Inhibitor of Metalloproteinase-1 - blood; Tissue Inhibitor of Metalloproteinase-2 - blood; Ventricular Remodeling; Hypertension; Heart failure; Cardiovascular disease; hypertrophy; matrix metalloproteinases; Heart disease